Literature DB >> 6193414

Characterization of a phosphoprotein associated with the SS-B/La nuclear antigen in adenovirus-infected and uninfected KB cells.

L I Pizer, J S Deng, R M Stenberg, E M Tan.   

Abstract

We have employed sera from patients with autoimmune disease to characterize the nuclear SS-B/La antigen in uninfected and adenovirus-infected KB cells. A 45,000-dalton phosphorylated polypeptide was specifically precipitated with anti-SS-B sera, and the level of phosphorylation was increased after infection. The increased phosphorylation appears to occur at the same amino acid residues phosphorylated in uninfected cells and results from increased phosphorylating activity rather than from altered enzyme specificity. A competition experiment between infected and uninfected cell extracts indicates that the antigen in the infected cell binds more strongly to SS-B/La antibodies. Fragments of adenovirus-induced virus-associated RNA as well as intact molecules complex with SS-B/La antigen and are immune precipitated with autoimmune sera.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193414      PMCID: PMC370114          DOI: 10.1128/mcb.3.7.1235-1245.1983

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Differentiation and characterization of autoantibodies and their antigens in Sjögren's syndrome.

Authors:  M A Alspaugh; N Talal; E M Tan
Journal:  Arthritis Rheum       Date:  1976 Mar-Apr

3.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

4.  Primary sequence of U-1 nuclear ribonucleic acid of Novikoff hepatoma ascites cells.

Authors:  R Reddy; T S Ro-Choi; D Henning; H Busch
Journal:  J Biol Chem       Date:  1974-10-25       Impact factor: 5.157

5.  Intracellular uncoating of type 5 adenovirus deoxyribonucleic acid.

Authors:  W C Lawrence; H S Ginsberg
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

6.  Two-dimensional gel electrophoresis of membrane proteins.

Authors:  G F Ames; K Nikaido
Journal:  Biochemistry       Date:  1976-02-10       Impact factor: 3.162

7.  Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen.

Authors:  M Mattioli; M Reichlin
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug

8.  Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells.

Authors:  L P Villarreal; M Breindl; J J Holland
Journal:  Biochemistry       Date:  1976-04-20       Impact factor: 3.162

9.  Role of DNA-dependent RNA polymerases II and III in transcription of the adenovirus genome late in productive infection.

Authors:  R Weinmann; H J Raskas; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

10.  A soluble acidic protein of the cell nucleus which reacts with serum from patients with systemic lupus erythermatosus and Sjögren's syndrome.

Authors:  M Akizuki; R Powers; H R Holman
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

View more
  16 in total

1.  Analysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets.

Authors:  E A Stea; J G Routsias; M Samiotaki; G Panayotou; E Papalambros; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases.

Authors:  A G Terzoglou; J G Routsias; S Avrameas; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

3.  The small nuclear ribonucleoprotein SS-B/La binds RNA with a conserved protease-resistant domain of 28 kilodaltons.

Authors:  E K Chan; E M Tan
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

4.  Phosphorylation of the Saccharomyces cerevisiae La protein does not appear to be required for its functions in tRNA maturation and nascent RNA stabilization.

Authors:  K S Long; T Cedervall; C Walch-Solimena; D A Noe; M J Huddleston; R S Annan; S L Wolin
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

5.  Mosquito homolog of the La autoantigen binds to Sindbis virus RNA.

Authors:  N Pardigon; J H Strauss
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

6.  La antigen recognizes and binds to the 3'-oligouridylate tail of a small RNA.

Authors:  M B Mathews; A M Francoeur
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

7.  Characterization and purification of lupus antigen La, and RNA-binding protein.

Authors:  A M Francoeur; E K Chan; J I Garrels; M B Mathews
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

8.  La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA.

Authors:  T Heise; L G Guidotti; F V Chisari
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

9.  Synthesis of small nuclear ribonucleoprotein particles by the malarial parasite Plasmodium falciparum.

Authors:  A M Francoeur; C A Gritzmacher; C L Peebles; R T Reese; E M Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

10.  Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity.

Authors:  C Baboonian; P J Venables; J Booth; D G Williams; L M Roffe; R N Maini
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.